Sector consensus GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
07:05:08 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 2,928.20 INR | -1.00% |
|
-4.00% | +18.38% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,315.56 | +14.46% | 29 | ||||||
| 275.64 | +0.15% | 22 | ||||||
| 276.59 | +7.85% | 29 | ||||||
| 371.42 | +5.04% | 18 | ||||||
| 155.53 | +0.28% | 21 | ||||||
| 212.81 | +30.49% | 22 | ||||||
| 388.72 | -11.09% | 29 | ||||||
| 309.3 | +3.46% | 23 | ||||||
| 157.41 | +4.25% | 27 | ||||||
| 28.61 | +0.55% | 26 | ||||||
| 569.54 | +4.29% | 26 | ||||||
| 66.21 | -0.92% | 24 | ||||||
| 94.45 | +24.79% | 23 | ||||||
| 21.64 | +17.76% | 20 | ||||||
| 9,323.33 | +42.04% | 15 | ||||||
| 6,603.31 | +14.3% | 16 | ||||||
| 57.94 | +18.96% | 18 | ||||||
| 71.35 | +54.25% | 17 | ||||||
| 41.6 | +14.41% | 10 | ||||||
| Average | 1,070.58 | +12.91% | 22 | ||||||
| Weighted average by Cap. | 704.98 | +8.68% | 24 |
Select your edition
All financial news and data tailored to specific country editions
